Target intelligence / Profile preview

Human skin barrier lipids and keratin (SC barrier)

Target
SC barrier
Molecular classification
Structural protein, Lipid, Other
01

Overview

The human skin barrier, primarily located in the stratum corneum, consists of a brick and mortar structure where keratin-filled corneocytes (bricks) are embedded in a complex lipid matrix (mortar) composed of ceramides, cholesterol, and free fatty acids (StatPearls, 2023). This barrier is essential for preventing excessive transepidermal water loss and protecting the body from environmental pathogens, allergens, and chemical irritants (PubMed, PMID: 18306158). Keratins provide structural integrity and mechanical strength to the epidermis, while the lipid lamellae ensure permeability control (UniProt, P04264). Dysregulation or depletion of these components is a hallmark of inflammatory skin diseases such as atopic dermatitis and psoriasis, where the barrier is compromised (NIH, 2021). Therapeutic interventions often target this barrier through the application of emollient lipids to restore the matrix or keratolytic agents to modulate the shedding of keratinized cells (Journal of Clinical Medicine, 2022). Understanding the interplay between these lipids and proteins is crucial for developing effective topical delivery systems and barrier-repairing formulations (Wikipedia, Stratum corneum).

Other names
Stratum corneum barrierEpidermal barrierSkin moisture barrierCorneocyte-lipid matrixSkin permeability barrier
02

Mechanism of action

Therapeutic agents interact with the skin barrier through several mechanisms: occlusion (forming a physical film to prevent water loss), humectancy (drawing water into the stratum corneum), emolliency (filling gaps between corneocytes with lipids), and keratolysis (breaking down keratin aggregates to facilitate desquamation).

03

Biological functions

Permeability barrierPhysical protectionAntimicrobial defenseHydration maintenanceDesquamation
04

Disease associations

Atopic dermatitisPsoriasisIchthyosisXerosisContact dermatitis
05

Safety considerations

Skin irritationAllergic contact dermatitisPotential for increased systemic absorption of co-administered drugsFolliculitis from heavy occlusionBarrier thinning from chronic keratolytic use
06

Interacting drugs

Ceramides

7 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)CorneometrySkin surface pHCeramide-to-cholesterol ratioFilaggrin degradation products

Beyond the preview

Go deeper on Human skin barrier lipids and keratin (SC barrier).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human skin barrier lipids and keratin (SC barrier).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call